Drug profile · INN
valbenazine
VALBENAZINE
valbenazine (VALBENAZINE) is a synaptic vesicular amine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — valbenazine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 6
- Programs
- 9
- Data quality
- 0.84
Quick answer
valbenazine (VALBENAZINE) is a synaptic vesicular amine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Synaptic vesicular amine transporter inhibitor
Primary target: Synaptic vesicular amine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11311532
High dosage valbenazine formulation and compositions, methods, and kits related thereto
granted -
US 11026939
High dosage valbenazine formulation and compositions, methods, and kits related thereto
granted -
US 10851103
Valbenazine salts and polymorphs thereof
granted -
US 10851104
Valbenazine salts and polymorphs thereof
granted -
US 10844058
Valbenazine salts and polymorphs thereof
granted -
US 10065952
Valbenazine salts and polymorphs thereof
granted
Frequently asked questions
What is valbenazine?
valbenazine (VALBENAZINE) is a synaptic vesicular amine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for valbenazine?
VALBENAZINE is a marketed brand name for valbenazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of valbenazine?
valbenazine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.